Stevanato Group S.p.a. (STVN)

$30.07

-1.6

(-5.05%)

Market is closed - opens 8 PM, 21 Feb 2024

Insights on Stevanato Group S.p.a.

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 237.99M → 271.4M (in $), with an average increase of 6.4% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, 28.26M → 37.9M (in $), with an average increase of 13.6% per quarter

  • Vs ISRG

    In the last 1 year, Intuitive Surgical, Inc. has given 58.5% return, outperforming this stock by 9.2%

Performance

  • $30.07
    $31.98
    $30.07
    downward going graph

    0.0%

    Downside

    Day's Volatility :5.97%

    Upside

    5.97%

    downward going graph
  • $19.81
    $36.30
    $30.07
    downward going graph

    34.12%

    Downside

    52 Weeks Volatility :45.43%

    Upside

    17.16%

    downward going graph

Returns

PeriodStevanato Group S.p.a.Sector (Health Care)Index (Russel 2000)
3 Months
13.43%
12.9%
0.0%
6 Months
1.12%
9.1%
0.0%
1 Year
57.8%
10.3%
-9.1%
3 Years
61.01%
27.3%
-22.0%

Highlights

Market Capitalization
8.9B
Book Value
$4.13
Dividend Share
0.054
Dividend Yield
0.18%
Earnings Per Share (EPS)
0.6
PE Ratio
55.63
PEG Ratio
3.57
Wall Street Target Price
34.56
Profit Margin
14.08%
Operating Margin TTM
18.9%
Return On Assets TTM
7.29%
Return On Equity TTM
14.45%
Revenue TTM
1.1B
Revenue Per Share TTM
3.99
Quarterly Revenue Growth YOY
10.7%
Gross Profit TTM
319.8M
EBITDA
267.4M
Diluted Eps TTM
0.6
Quarterly Earnings Growth YOY
0.02
EPS Estimate Current Year
0.64
EPS Estimate Next Year
0.72
EPS Estimate Current Quarter
0.16
EPS Estimate Next Quarter
0.21

Analyst Recommendation

Buy
    81%Buy
    18%Hold
    0
    0%Sell
Based on 16 Wall street analysts offering stock ratings for Stevanato Group S.p.a.(by analysts ranked 0 to 5 stars)
Based on 16 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
13
12
Hold
3
3
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 14.93%

Current $30.07
Target $34.56

Company Financials

FY19Y/Y Change
Revenue
601.0M
-
Net Income
43.9M
-
Net Profit Margin
7.31%
-
FY20Y/Y Change
Revenue
814.3M
↑ 23.39%
Net Income
96.6M
↑ 100.28%
Net Profit Margin
11.86%
↑ 4.55%
FY21Y/Y Change
Revenue
955.7M
↑ 27.47%
Net Income
152.1M
↑ 71.05%
Net Profit Margin
15.91%
↑ 4.05%
FY22Y/Y Change
Revenue
1.1B
↑ 16.57%
Net Income
153.2M
↑ 6.48%
Net Profit Margin
14.54%
↓ 1.37%
FY23Y/Y Change
Revenue
1.1B
↑ 7.43%
Net Income
148.8M
↑ 4.04%
Net Profit Margin
14.08%
↓ 0.46%
Q2 FY22Q/Q Change
Revenue
244.7M
↑ 10.46%
Net Income
31.9M
↑ 10.13%
Net Profit Margin
13.03%
↓ 0.04%
Q3 FY22Q/Q Change
Revenue
241.1M
↑ 4.7%
Net Income
35.6M
↑ 18.62%
Net Profit Margin
14.77%
↑ 1.74%
Q4 FY22Q/Q Change
Revenue
312.9M
↑ 19.1%
Net Income
51.7M
↑ 33.37%
Net Profit Margin
16.54%
↑ 1.77%
Q1 FY23Q/Q Change
Revenue
259.5M
↓ 18.52%
Net Income
30.8M
↓ 41.48%
Net Profit Margin
11.88%
↓ 4.66%
Q2 FY23Q/Q Change
Revenue
278.6M
↑ 7.27%
Net Income
37.4M
↑ 21.35%
Net Profit Margin
13.44%
↑ 1.56%
Q3 FY23Q/Q Change
Revenue
271.4M
↑ 6.31%
Net Income
37.9M
↑ 10.5%
Net Profit Margin
13.96%
↑ 0.52%
FY18Y/Y Change
Total Assets
894.2M
-
Total Liabilities
629.4M
-
FY19Y/Y Change
Total Assets
988.2M
↑ 12.87%
Total Liabilities
690.9M
↑ 12.1%
FY20Y/Y Change
Total Assets
1.2B
↑ 9.73%
Total Liabilities
809.2M
↑ 6.66%
FY21Y/Y Change
Total Assets
1.6B
↑ 46.54%
Total Liabilities
653.7M
↓ 12.26%
FY22Y/Y Change
Total Assets
1.8B
↑ 16.99%
Total Liabilities
711.1M
↑ 15.0%
Q2 FY22Q/Q Change
Total Assets
1.6B
↑ 4.83%
Total Liabilities
651.5M
↑ 6.98%
Q3 FY22Q/Q Change
Total Assets
1.6B
↑ 5.84%
Total Liabilities
653.8M
↑ 6.65%
Q4 FY22Q/Q Change
Total Assets
1.8B
↑ 1.92%
Total Liabilities
711.1M
↓ 0.2%
Q1 FY23Q/Q Change
Total Assets
1.9B
↑ 5.04%
Total Liabilities
777.1M
↑ 7.36%
Q2 FY23Q/Q Change
Total Assets
2.0B
↑ 3.76%
Total Liabilities
437.0M
↓ 43.8%
Q3 FY23Q/Q Change
Total Assets
1.9B
↑ 6.54%
Total Liabilities
377.3M
↓ 5.79%
FY19Y/Y Change
Operating Cash Flow
47.7M
-
Investing Cash Flow
-83.3M
-
Financing Cash Flow
47.2M
-
FY20Y/Y Change
Operating Cash Flow
191.5M
↑ 265.63%
Investing Cash Flow
-118.2M
↑ 29.26%
Financing Cash Flow
-32.6M
↓ 162.88%
FY21Y/Y Change
Operating Cash Flow
151.0M
↓ 14.36%
Investing Cash Flow
-109.2M
↑ 0.35%
Financing Cash Flow
288.6M
↓ 1060.89%
FY22Y/Y Change
Operating Cash Flow
110.7M
↓ 22.51%
Investing Cash Flow
-260.3M
↑ 151.95%
Financing Cash Flow
-47.7M
↓ 117.46%
Q2 FY22Q/Q Change
Operating Cash Flow
44.1M
↑ 720.02%
Investing Cash Flow
-79.7M
↑ 39.58%
Financing Cash Flow
-20.0M
↓ 716.67%
Q3 FY22Q/Q Change
Operating Cash Flow
-3.7M
↓ 108.97%
Investing Cash Flow
-42.5M
↓ 43.38%
Financing Cash Flow
-9.7M
↓ 48.19%
Q4 FY22Q/Q Change
Operating Cash Flow
64.0M
↓ 1676.45%
Investing Cash Flow
-73.7M
↑ 59.28%
Financing Cash Flow
-19.9M
↑ 87.73%
Q1 FY23Q/Q Change
Operating Cash Flow
40.5M
↓ 37.8%
Investing Cash Flow
-104.6M
↑ 39.35%
Financing Cash Flow
24.0M
↓ 218.28%
Q2 FY23Q/Q Change
Operating Cash Flow
26.6M
↓ 34.29%
Investing Cash Flow
-104.6M
↑ 0.0%
Financing Cash Flow
-27.7M
↓ 215.45%
Q3 FY23Q/Q Change
Operating Cash Flow
33.5M
↑ 37.3%
Investing Cash Flow
-132.2M
↑ 37.85%
Financing Cash Flow
101.7M
↓ 500.39%

Technicals Summary

Sell

Neutral

Buy

Stevanato Group S.p.a. is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Stevanato Group S.p.a.
Stevanato Group S.p.a.
10.73%
1.12%
57.8%
61.01%
61.01%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
0.75%
32.08%
62.1%
53.21%
106.66%
Becton, Dickinson And Company
Becton, Dickinson And Company
2.06%
-12.65%
0.53%
-2.14%
-3.33%
Alcon Ag
Alcon Ag
-1.92%
-7.29%
6.45%
8.36%
33.6%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Stevanato Group S.p.a.
Stevanato Group S.p.a.
55.63
55.63
3.57
0.64
0.14
0.07
0.0
4.13
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
75.73
75.73
5.58
6.26
0.15
0.08
NA
37.77
Becton, Dickinson And Company
Becton, Dickinson And Company
54.91
54.91
1.34
12.94
0.05
0.03
0.02
87.68
Alcon Ag
Alcon Ag
85.24
85.24
1.07
2.72
0.02
0.02
0.0
40.86
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Stevanato Group S.p.a.
Stevanato Group S.p.a.
Buy
$8.9B
61.01%
55.63
14.08%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$133.9B
106.66%
75.73
25.24%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$69.3B
-3.33%
54.91
6.44%
Alcon Ag
Alcon Ag
Buy
$38.1B
33.6%
85.24
4.85%

Institutional Holdings

  • Conestoga Capital Advisors, LLC

    1.72%
  • Neuberger Berman Group LLC

    1.18%
  • Lazard Asset Management LLC

    1.01%
  • Copeland Capital Management, LLC

    0.79%
  • TimesSquare Capital Management, LLC

    0.77%
  • Sands Capital Management, LLC

    0.70%

Company Information

founded in 1949, stevanato group is committed to create systems, processes and services that guarantee the integrity of parenteral medicines. it is comprised of two operational divisions: - pharmaceutical systems (ompi and balda brands): specialized in ready-to-use glass containers and bulk primary packaging (syringes, cartridges, vials and ampoules); high quality and high precision plastic solutions for diagnostic, pharmaceutical and medical device applications. - engineering systems (spami, optrel, innoscan and svm brands): specialized in glass forming technology, inspection systems, assembly, packaging machines and serialization solutions for the pharmaceutical industry. these two divisions enjoy a close, synchronous relationship, featuring daily exchanges which ensure that stevanato group has complete control over the entire production process, from purchasing the finest raw materials to offering exceptional after-sales customer service. the group also benefits from the sglab activ

Organization
Stevanato Group S.p.a.
Employees
5260
CEO
Mr. Franco Stevanato
Industry
Basic materials

FAQs